ArticleJournal of synchrotron radiation2025
Macromolecular crystallography at SPring-8 and SACLA.
Article in Journal of synchrotron radiation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Sharper, smaller, brighter: enhanced optical performance at the X06DA-PXIII beamline after the SLS 2.0 upgrade.Journal of synchrotron radiation · 2026Article
- Synchrotron structural biology at SSRL, the beginning and beyond.Journal of synchrotron radiation · 2026Article
- 50th anniversary of the Stanford SSRL synchrotron radiation and protein crystallography initiative.Journal of synchrotron radiation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Since the groundbreaking determination of the first protein crystal structure by J. C. Kendrew in 1959, macromolecular crystallography (MX) has remained at the forefront of structural biology, driven by continuous technological advancements. The advent of synchrotron radiation in the 1990s revolutionized the field, enhancing data quality, introducing novel phasing methods, and broadening the scope of target samples to include membrane proteins and supramolecular complexes. In 1997, Japan inaugurated SPring-8, one of the world's largest third-generation synchrotron radiation facilities. With its high-brilliance radiation from insertion devices, SPring-8 has dramatically increased the capability of MX. This paper describes MX's evolution, current developments, and prospects at SPring-8 and SACLA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.